why thiamine matters
In brief
Every cell needs energy, and thiamine is required at several key steps where the body turns food into that energy. When thiamine runs short, the organs that use the most energy are hit first: the brain, the nerves and the heart.
Severe deficiency causes well-recognised and potentially fatal diseases: beriberi and Wernicke encephalopathy. These are preventable and, if caught early, often treatable. They still occur today, including in wealthy countries, and they are frequently missed.
Key points
Thiamine is needed to release energy from glucose and from some amino acids.
The brain is especially dependent on it, because the brain runs mainly on glucose and uses about a fifth of the body's resting energy.
Severe deficiency can damage the nervous system (dry beriberi, Wernicke encephalopathy, Korsakoff syndrome) and the heart (wet beriberi).
Deficiency is not just historical. It occurs in alcohol use disorder, after bariatric surgery, with persistent vomiting, in critical illness, and in infants in some parts of the world.
Autopsy studies show that Wernicke encephalopathy is often not diagnosed during life.
Research into thiamine's role in common chronic conditions is active but largely unsettled.
The energy connection
A useful way to picture thiamine is as a gatekeeper at metabolic junctions. Food is broken down step by step. At certain points, a molecule has to pass through an enzyme that only works when its thiamine-based helper, thiamine pyrophosphate (TPP), is present.
The most important of these gates sits between two major stages of energy production:
Glycolysis, which splits glucose into pyruvate and yields a small amount of energy.
The Krebs cycle and oxidative phosphorylation in mitochondria, which yield most of the cell's energy.
Without enough TPP, pyruvate cannot pass efficiently into the mitochondria. Cells then produce much less energy and accumulate lactate instead. This is why lactic acidosis can be a sign of severe deficiency.
For the full picture of how this works, see How the Body Uses Thiamine.
The organs most at risk
Brain
High, constant energy demand; relies mainly on glucose
Confusion, impaired memory, problems with balance and eye movements (Wernicke encephalopathy); lasting memory loss (Korsakoff syndrome)
Peripheral nerves
Long nerve fibres need a continuous energy supply
Numbness, tingling, burning, weakness, mainly in the legs (dry beriberi)
Heart and blood vessels
Heart muscle works continuously
Fast heart rate, breathlessness, fluid retention, heart failure (wet beriberi)
Digestive system
Smooth muscle and gut lining have high turnover and energy needs
Nausea, abdominal pain, vomiting (described as gastrointestinal beriberi)
Autonomic nervous system
Controls heart rate, blood pressure, digestion and sweating
Dizziness on standing, abnormal sweating and other autonomic symptoms (described in beriberi)
Diseases caused by deficiency
Dry beriberi
Nerve damage (peripheral neuropathy), mainly affecting the legs
Wet beriberi
Heart involvement with fluid retention and heart failure
Shoshin beriberi
A rapid, severe form of wet beriberi with lactic acidosis and circulatory collapse; a medical emergency
Wernicke encephalopathy
Acute brain dysfunction; a medical emergency
Korsakoff syndrome
Severe, often lasting memory impairment, usually after Wernicke encephalopathy
Infantile beriberi
Occurs in breastfed infants of thiamine-deficient mothers; can be rapidly fatal
These conditions are covered in detail in the Health Conditions section. Symptoms are summarised in Symptoms of Low Thiamine.
Not a disease of the past
Fortification greatly reduced beriberi in many countries, but thiamine deficiency persists. Examples include:
Alcohol use disorder, the most common setting in high-income countries.
Bariatric (weight-loss) surgery, especially when complicated by vomiting.
Hyperemesis gravidarum (severe vomiting in pregnancy).
Eating disorders, prolonged fasting and malnutrition.
Critical illness, refeeding after starvation, and long-term intravenous nutrition without adequate vitamins.
Infants in parts of South and Southeast Asia, where diets rely heavily on polished rice and maternal intake is low.
Humanitarian settings, such as refugee camps dependent on limited food rations.
A striking modern example occurred in Israel in 2003, when a soy-based infant formula was found to contain almost no thiamine. Infants developed severe deficiency; several died and others were left with lasting neurological problems.
Why it is easily missed
In a landmark autopsy study of 131 people with brain changes of Wernicke encephalopathy, only about one in five had been diagnosed during life. Many did not show the full "textbook" set of symptoms.
Reasons deficiency is missed include:
Early symptoms such as fatigue, irritability and poor appetite are non-specific.
The classic signs often appear incompletely.
Blood tests have limitations and are not always available quickly (see Testing Limitations).
It is often not considered outside the setting of heavy alcohol use.
Areas of active research
Beyond classic deficiency disease, researchers are investigating whether thiamine status plays a role in more common conditions. The research is at very different stages in each area.
Diabetes
Low plasma thiamine is common in people with diabetes, linked to increased loss through the kidneys
Heart failure with diuretic use
Loop diuretics such as furosemide increase urinary thiamine loss
Critical illness and sepsis
Deficiency is common in intensive care; trials of thiamine in septic shock have shown mixed results
Neurodegenerative disease
Reduced activity of thiamine-dependent enzymes in Alzheimer's disease brains; small trials of derivatives such as benfotiamine
Fatigue
A small randomised controlled trial in inflammatory bowel disease reported reduced fatigue with high-dose oral thiamine
Functional disorders (e.g. dysautonomia, ME/CFS)
Proposed mechanisms and case reports
Open questions
How common mild or "subclinical" deficiency is in the general population, and whether it has health effects.
Whether thiamine supplementation improves outcomes in diabetes, heart failure, sepsis or neurodegenerative disease.
Whether blood tests reflect thiamine status in the brain and other tissues.
Related pages
What Is Thiamine?
How the Body Uses Thiamine
Symptoms of Low Thiamine
Causes of Deficiency
Common Misconceptions
References
Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. Journal of Neurology, Neurosurgery & Psychiatry. 1986;49(4):341–345.
Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology. 2007;6(5):442–455.
Whitfield KC, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Annals of the New York Academy of Sciences. 2018;1430(1):3–43.
Smith TJ, et al. Thiamine deficiency disorders: a clinical perspective. Annals of the New York Academy of Sciences. 2021;1498(1):9–28.
Fattal-Valevski A, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics. 2005;115(2):e233–e238.
Thornalley PJ, et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 2007;50(10):2164–2170.
Seligmann H, et al. Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. American Journal of Medicine. 1991;91(2):151–155.
Donnino MW, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Critical Care Medicine. 2016;44(2):360–367.
Bager P, et al. Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2021;53(1):79–86.
Gibson GE, et al. Benfotiamine and cognitive decline in Alzheimer's disease: results of a randomized placebo-controlled phase IIa clinical trial. Journal of Alzheimer's Disease. 2020;78(3):989–1010.
Was this helpful?

